04:51 PM EDT, 07/25/2025 (MT Newswires) -- Aptevo Therapeutics ( APVO ) filed a registration statement with the US Securities and Exchange Commission on Friday covering the sale of up to nearly 8.3 million of its shares by YA II PN.

The company said the shares being offered by the selling shareholder will be issued under a purchase agreement that it signed with YA.

Aptevo said it's not selling any securities under the prospectus and won't get receive any of the proceeds from the sale of its shares by YA.

The company also said, however, it may receive up to $25 million in gross proceeds from sales of its shares to YA that it may make under the purchase agreement during the 36 months following the execution of the agreement.

Aptevo shares were falling 2.3% in recent after-hours activity.